U of T startup Bridge7 using artificial intelligence to improve cancer treatment
Summary
The tech giant’s Global Accelerator Program was created to foster companies that focus on local issues, helping them address their specific markets and giving them access to Google’s resources. That was also a great experience and we have made long lasting contacts there, gained valuable advice on fundraising and building our company.” When asked how it felt to see one of UTEST’s incubated companies succeed so well, program co-director Kurtis Scissons claimed that it is one of the most rewarding parts of the job. “Bridge7 is a great example of a company that is led by a highly motivated and technical team which established its first, recurring revenue customer within a year after graduating from the UTEST program,” Scissons wrote in an email to The Varsity. “We provided fundamental business education with our partner MaRS, mentorship and a physical location for the company at our ONRamp facility,” Scissons wrote. “Business introductions were facilitated by the UTEST team that has helped identify new customers and potential investors.” Bridge7 uses AI to accelerate the triaging and treatment planning process of cancer patients.